To address the possible role of replicative senescence in human immunodeficiency virus (HIV) infection, telomere length, telomerase activity, and in vitro replicative capacity were assessed in peripheral blood T cells from HIV+ and HIV− donors. Genetic and age-specific effects on these parameters were controlled by studying HIV-discordant pairs of monozygotic twins. Telomere terminal restriction fragment (TRF) lengths from CD4+ T cells of HIV+ donors were significantly greater than those from HIV− twins. In contrast, telomere lengths in CD8+ T cells from HIV+ donors were shorter than in HIV− donors. The in vitro replicative capacity of CD4+ cells from HIV+ donors was equivalent to that of HIV− donors in response to stimulation through T cell receptor CD3 and CD28. Little or no telomerase activity was detected in freshly isolated CD4+ or CD8+ lymphocytes from HIV+ or HIV− donors, but was induced by in vitro stimulation of both HIV+ and HIV− donor cells. These results suggest that HIV infection is associated with alterations in the population dynamics of both CD4+ and CD8+ T cells, but fail to provide evidence for clonal exhaustion or replicative senescence as a mechanism underlying the decline in CD4+ T cells of HIV-infected donors.
Skip Nav Destination
Article navigation
7 April 1997
Article|
April 07 1997
Telomere Length, Telomerase Activity, and Replicative Potential in HIV Infection: Analysis of CD4+ and CD8+T Cells from HIV-discordant Monozygotic Twins
Larry D. Palmer,
Larry D. Palmer
From the *Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892; ‡Immune Cell Biology Program, Naval Medical Research Institute, Bethesda, Maryland 20889; §Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892; and ¶National Institute on Aging, National Institutes of Health, Bethesda, Maryland 20892
Search for other works by this author on:
Nan-ping Weng,
Nan-ping Weng
From the *Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892; ‡Immune Cell Biology Program, Naval Medical Research Institute, Bethesda, Maryland 20889; §Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892; and ¶National Institute on Aging, National Institutes of Health, Bethesda, Maryland 20892
Search for other works by this author on:
Bruce L. Levine,
Bruce L. Levine
From the *Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892; ‡Immune Cell Biology Program, Naval Medical Research Institute, Bethesda, Maryland 20889; §Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892; and ¶National Institute on Aging, National Institutes of Health, Bethesda, Maryland 20892
Search for other works by this author on:
Carl H. June,
Carl H. June
From the *Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892; ‡Immune Cell Biology Program, Naval Medical Research Institute, Bethesda, Maryland 20889; §Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892; and ¶National Institute on Aging, National Institutes of Health, Bethesda, Maryland 20892
Search for other works by this author on:
H. Clifford Lane,
H. Clifford Lane
From the *Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892; ‡Immune Cell Biology Program, Naval Medical Research Institute, Bethesda, Maryland 20889; §Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892; and ¶National Institute on Aging, National Institutes of Health, Bethesda, Maryland 20892
Search for other works by this author on:
Richard J. Hodes
Richard J. Hodes
From the *Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892; ‡Immune Cell Biology Program, Naval Medical Research Institute, Bethesda, Maryland 20889; §Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892; and ¶National Institute on Aging, National Institutes of Health, Bethesda, Maryland 20892
Search for other works by this author on:
Larry D. Palmer
From the *Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892; ‡Immune Cell Biology Program, Naval Medical Research Institute, Bethesda, Maryland 20889; §Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892; and ¶National Institute on Aging, National Institutes of Health, Bethesda, Maryland 20892
Nan-ping Weng
From the *Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892; ‡Immune Cell Biology Program, Naval Medical Research Institute, Bethesda, Maryland 20889; §Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892; and ¶National Institute on Aging, National Institutes of Health, Bethesda, Maryland 20892
Bruce L. Levine
From the *Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892; ‡Immune Cell Biology Program, Naval Medical Research Institute, Bethesda, Maryland 20889; §Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892; and ¶National Institute on Aging, National Institutes of Health, Bethesda, Maryland 20892
Carl H. June
From the *Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892; ‡Immune Cell Biology Program, Naval Medical Research Institute, Bethesda, Maryland 20889; §Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892; and ¶National Institute on Aging, National Institutes of Health, Bethesda, Maryland 20892
H. Clifford Lane
From the *Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892; ‡Immune Cell Biology Program, Naval Medical Research Institute, Bethesda, Maryland 20889; §Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892; and ¶National Institute on Aging, National Institutes of Health, Bethesda, Maryland 20892
Richard J. Hodes
From the *Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892; ‡Immune Cell Biology Program, Naval Medical Research Institute, Bethesda, Maryland 20889; §Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892; and ¶National Institute on Aging, National Institutes of Health, Bethesda, Maryland 20892
Address correspondence to Richard J. Hodes, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892.
1Abbreviations used in this paper: mpd, mean population doublings; TRAP, telomeric repeats amplification protocol; TRF, terminal restriction fragment.
Received:
November 18 1996
Revision Received:
January 23 1997
Online ISSN: 1540-9538
Print ISSN: 0022-1007
1997
J Exp Med (1997) 185 (7): 1381–1386.
Article history
Received:
November 18 1996
Revision Received:
January 23 1997
Citation
Larry D. Palmer, Nan-ping Weng, Bruce L. Levine, Carl H. June, H. Clifford Lane, Richard J. Hodes; Telomere Length, Telomerase Activity, and Replicative Potential in HIV Infection: Analysis of CD4+ and CD8+T Cells from HIV-discordant Monozygotic Twins. J Exp Med 7 April 1997; 185 (7): 1381–1386. doi: https://doi.org/10.1084/jem.185.7.1381
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement